Clinical Trial Update: Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on VM-1500's safety and pharmacokinetics in healthy volunteers, and its safety, tolerability, and antiviral activity in HIV-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VM-1500

Snippet

Sponsor: Viriom | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED